[Federal Register Volume 62, Number 161 (Wednesday, August 20, 1997)]
[Notices]
[Pages 44386-44387]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-22029]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Recombinant DNA Advisory Committee; Notice of Meeting
Pursuant to Pub. L. 92-463, notice is hereby given of a meeting of
the Recombinant DNA Advisory Committee on September 12, 1997. The
meeting will be held at the National Institutes of Health, Building
31C, 6th Floor, Conference Room 6, 9000 Rockville Pike, Bethesda,
Maryland 20892, starting on September 12, 1997, at approximately 9
a.m., and will recess at approximately 5 p.m. The meeting will be open
to the public to discuss Proposed Actions under the NIH Guidelines for
Research Involving Recombinant DNA Molecules (59 FR 34496) and other
matters to be considered by the Committee. The Proposed Actions to be
discussed will follow this notice of meeting. Attendance by the public
will be limited to space available.
Debra W. Knorr, Acting Director, Office of Recombinant DNA
Activities, National Institutes of Health, MSC 7010, 6000 Executive
Boulevard, Suite 302, Bethesda, Maryland 20892-7010, Phone (301) 496-
9838, FAX (301) 496-9839, will provide summaries of the meeting and a
roster of committee members upon request. Individuals who plan to
attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should contact Ms.
Knorr in advance of the meeting.
OMB's ``Mandatory Information Requirements for Federal Assistance
Program Announcements'' (45 FR 39592, June 11, 1980) requires a
statement concerning the official government programs contained in the
Catalog of Federal Domestic Assistance. Normally NIH lists in its
announcements the number and title of affected individual programs for
the guidance of the public. Because the guidance in this notice covers
not only virtually every NIH program but also essentially every Federal
research program in which DNA recombinant molecule techniques could be
used, it has been determined not to be cost effective or in the public
interest to attempt to list these programs. Such a list would likely
require several additional pages. In addition, NIH could not be certain
that every Federal program would be included as many Federal agencies,
as well as private organizations, both national and international, have
elected to follow the NIH Guidelines. In lieu of the individual program
listing, NIH invites readers to direct questions to the information
address above about whether individual programs listed in the Catalog
of Federal Domestic Assistance are affected.
[[Page 44387]]
Dated: August 11, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-22029 Filed 8-19-97; 8:45 am]
BILLING CODE 4140-01-P
